Study summary

This study will test a drug called enfortumab vedotin in participants with a type of bladder cancer called non-muscle invasive bladder cancer (NMIBC).

This study will also evaluate what the side effects are and if the drug works to treat NMIBC. A side effect is anything a drug does to your body besides treating your disease.

In this study enfortumab vedotin will be put into the bladder using a catheter. A catheter is a thin tube that can be put into your bladder.

Additional Study Details

Phase
Phase 1
Product
enfortumab vedotin
Product
Enfortumab vedotin
Type
Interventional
Masking
None (Open Label)
Enrollment number
37
Show Additional Study Details

Get more information

Would you like more information about clinical trial sites that are recruiting participants for A Study of Intravesical Enfortumab Vedotin For Treatment of Patients With Non-muscle Invasive Bladder Cancer (NMIBC)? Contact us by filling out your information to the right and we’ll respond to you.

  • A caregiver
  • A healthcare provider
  • A parent
  • A patient
  • A patient advocate
  • Algeria
  • Argentina
  • Armenia
  • Australia
  • Austria
  • Belarus
  • Belgium
  • Bosnia And Herzegovina
  • Brazil
  • Bulgaria
  • Canada
  • Chile
  • China
  • Colombia
  • Croatia
  • Czech Republic
  • Denmark
  • Dominican Republic
  • Egypt
  • Estonia
  • Finland
  • Former Serbia and Montenegro
  • France
  • Georgia
  • Germany
  • Greece
  • Guatemala
  • Hong Kong
  • Hungary
  • Iceland
  • India
  • Indonesia
  • Ireland
  • Israel
  • Italy
  • Japan
  • Jordan
  • Kazakhstan
  • Latvia
  • Lebanon
  • Lithuania
  • Macedonia
  • Malaysia
  • Mexico
  • Montenegro
  • Morocco
  • Netherlands
  • New Zealand
  • Norway
  • Panama
  • Peru
  • Philippines
  • Poland
  • Portugal
  • Puerto Rico
  • Republic of Korea
  • Republic of Moldova
  • Romania
  • Russian Federation
  • Saudi Arabia
  • Serbia
  • Singapore
  • Slovakia
  • Slovenia
  • South Africa
  • Spain
  • Sweden
  • Switzerland
  • Taiwan, Province of China
  • Thailand
  • Turkey
  • Ukraine
  • United Kingdom
  • United States
  • Vietnam

By clicking ["Continue/Submit"], you agree that Astellas may contact you by email with information to help you connect with clinical trial sites. While we can connect you to clinical trial sites, we cannot answer questions about any investigational therapy through email. Your consent to receiving emails is not a requirement to participate in a clinical trial or study. For more information, including how to unsubscribe at any time, see our Privacy Notice & Cookies Policy.

    Locations

    Contact Us
    Contact Us
    Recruiting
    MD Anderson
    Houston, TX, United States, 77030
    Completed
    Laura & Isaac Perlmutter Cancer Center at NYU Langone Health
    New York, NY, United States, 10016
    Recruiting
    Johns Hopkins Medical Center
    Baltimore, MD, United States, 21287
    Completed
    Duke University Medical Center
    Durham, NC, United States, 27710
    Recruiting
    University of California, Irvine
    Orange, CA, United States, 92868
    Recruiting
    Site ES34001
    Barcelona, Spain, 08025
    Recruiting
    University of Texas Southwestern Medical Center
    Dallas, TX, United States, 75390
    Recruiting
    Site CA11001
    Toronto, Ontario, Canada, M5G 2C1
    Recruiting
    Site FR33001
    Paris, France, 75013
    Recruiting
    University of California at San Francisco
    San Francisco, CA, United States, 94134
    Recruiting
    Site ES34003
    Barcelona, Spain, 08036
    Recruiting
    Site ES34002
    Madrid, Spain, 28041
    Recruiting
    Site UK44002
    London, United Kingdom, EC1A 7BE
    Recruiting
    UCLA Department of Medicine - Hematology & Oncology
    Los Angeles, CA, United States, 90095
    Recruiting
    Banner MD Anderson Cancer Center
    Gilbert, Arizona, United States, 85234
    Recruiting
    James Cancer Hospital / Ohio State University
    Columbus, Ohio, United States, 43221
    Recruiting
    Carolina Urologic Research Center
    Myrtle Beach, South Carolina, United States, 29572
    Recruiting
    Urology San Antonio
    San Antonio, Texas, United States, 78229
    Recruiting
    Fred Hutchinson Cancer Center / Seattle Cancer Care Alliance / University of Washington
    Seattle, Washington, United States, 98195
    Recruiting
    Mayo Clinic
    Scottsdale, Arizona, United States, 85259
    Recruiting
    Northwestern University-Feinberg School of Medicine
    Chicago, Illinois, United States, 60611
    Recruiting
    Site FR33002
    Lyon, France, 69003
    Recruiting
    Site ES34004
    Barcelona, Spain, 08035
    Recruiting
    Site DE49001
    Goettingen, Germany, 37075
    Recruiting
    Markey Cancer Center / University of Kentucky
    Lexington, Kentucky, United States, 40508
    Recruiting
    Erlanger Oncology and Hematology
    Chattanooga, Tennessee, United States, 37403
    Recruiting
    Site DE49002
    Tübingen, Germany, 72076
    Recruiting
    Sidney Kimmel Cancer Center
    Philadelphia, Pennsylvania, United States, 19107
    Recruiting
    Site FR33003
    Rennes, France, 35000
    Recruiting
    Rush University Medical Center
    Chicago, IL, United States, 60612
    Recruiting
    Stanford Health Care
    Stanford, CA, United States, 94305
    Recruiting
    Oregon Health and Science University
    Portland, OR, United States, 98682

    Frequently Asked Questions

    Are clinical trials only for people with advanced cancer?

    While some clinical trials may focus on more advanced cancers, many trials are open to patients at various stages of their cancer. Each study has rules about who can take part. For example, only patients in a certain age group or those who have a certain type of tumor may be able to join.

    Will I have to stop my current treatment to participate in a clinical trial?

    Sometimes researchers want participants to keep taking their current treatments during a clinical trial. Other times, you may need to stop your current treatments for a while. If the investigational treatment doesn't work, you can usually go back to your original treatment plan.

    Should I be worried about getting a placebo?

    In cancer clinical trials, a placebo is only used if there is no other treatment for that type of cancer. This helps compare an investigational treatment to the placebo. Placebos are rarely used in cancer trials because the best available treatment, called the “standard of care”, is usually given instead.

    Do I need a referral from my doctor to take part in a study?

    Your doctor may not know about all the opportunities for clinical trials that are available to you. Talk to your doctor or other medical provider about clinical trial information that you find. They can help you decide if a clinical trial is right for you. If you do not find any options on this website, we recommend you visit an online public registry website like clinicaltrials.gov to see a wide variety of available clinical trials.

    Explore More

    1

    What are clinical trials?

    2

    Why are Clinical Trials Important?

    3

    Why Participate in a Clinical Trial?